Showing results (191-200 of 3,095) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|May 24, 2022
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longerAlice Avancini, Lorenzo Belluomini, Anita Borsati, et al.Expert Review of Anticancer Therapy|May 25, 2022
Advanced delivery of leuprorelin acetate for the treatment of prostatic cancerAxel S Merseburger, Marie Christine RoeschExpert Review of Anticancer Therapy|May 11, 2022
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı, et al.Expert Review of Anticancer Therapy|May 9, 2022
Developments in personalized therapy for metastatic renal cell carcinomaRyo Fujiwara, Susumu Kageyama, Takeshi YuasaExpert Review of Anticancer Therapy|May 9, 2022
Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancerLevent Mutlu, Joan Tymon-Rosario, Justin Harold, et al.Expert Review of Anticancer Therapy|October 10, 2017
Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomasHanna Koseła-Paterczyk, Piotr RutkowskiExpert Review of Anticancer Therapy|October 10, 2017
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancerFrancesco Felicetti, Alice Nervo, Alessandro Piovesan, et al.Expert Review of Anticancer Therapy|April 28, 2023
Association between CD8+ tumor-infiltrating lymphocytes and prognosis of non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysisQi-Ming Zheng, Yuan-Yuan Li, Ye-Peng Wang, et al.Expert Review of Anticancer Therapy|May 1, 2023
A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancerDaniel Sur, Cristina Lungulescu, Elena Adriana Dumitrescu, et al.Expert Review of Anticancer Therapy|November 6, 2003
Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?Alba A Brandes, Myriam K Paris, Umberto BassoPageof 310